Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker UTHR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 280 | $597.33 | $167.3K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 662 | $596.22 | $394.7K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,409 | $595.17 | $838.6K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 3,079 | $594.24 | $1.8M Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,934 | $593.44 | $1.1M Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 551 | $592.32 | $326.4K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 317 | $591.10 | $187.4K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 359 | $590.11 | $211.8K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 427 | $589.21 | $251.6K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 323 | $588.30 | $190.0K Sale | Form 4 ↗ |
| Nov 12, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 159 | $587.00 | $93.3K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 247 | $598.63 | $147.9K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,299 | $597.61 | $776.3K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,324 | $596.74 | $790.1K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,346 | $595.46 | $801.5K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 991 | $594.66 | $589.3K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 961 | $593.57 | $570.4K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,172 | $592.68 | $694.6K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 736 | $591.56 | $435.4K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 301 | $590.31 | $177.7K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 292 | $589.18 | $172.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 271 | $588.16 | $159.4K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 320 | $586.59 | $187.7K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 215 | $585.93 | $126.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 25 | $584.20 | $14.6K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 80 | $592.93 | $47.4K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 120 | $592.20 | $71.1K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 960 | $590.95 | $567.3K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 2,040 | $589.95 | $1.2M Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 360 | $589.15 | $212.1K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 620 | $587.96 | $364.5K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 937 | $586.66 | $549.7K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 795 | $585.56 | $465.5K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 328 | $584.76 | $191.8K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 980 | $583.64 | $572.0K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 618 | $582.42 | $359.9K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 742 | $581.36 | $431.4K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 880 | $580.40 | $510.8K Sale | Form 4 ↗ |
| Nov 10, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 40 | $577.52 | $23.1K Sale | Form 4 ↗ |
| Nov 9, 2026 | Christopher Patusky Director | UTHR United Therapeutics Corporation | Sale | 1,210 | $580.00 | $701.8K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 280 | $585.63 | $164.0K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 840 | $584.70 | $491.1K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 494 | $583.80 | $288.4K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 1,732 | $582.79 | $1.0M Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 520 | $581.52 | $302.4K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 300 | $580.16 | $174.0K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 294 | $579.58 | $170.4K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 160 | $578.45 | $92.6K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 120 | $577.45 | $69.3K Sale | Form 4 ↗ |
| Nov 9, 2026 | Martine A. Rothblatt Chairperson & CEO, Director | UTHR United Therapeutics Corporation | Sale | 315 | $576.37 | $181.6K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances